histamine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
1375 51-45-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • ceplene
  • histamine
  • 5-imidazoleethylamine
  • eramin
  • ergamine
  • ergotidine
  • histamine dihydrochloride
  • histamine phosphate
  • histamine diphosphate
An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
  • Molecular weight: 111.15
  • Formula: C5H9N3
  • CLOGP: -0.97
  • LIPINSKI: 0
  • HAC: 3
  • HDO: 2
  • TPSA: 54.70
  • ALOGS: 0.17
  • ROTB: 2
  • Status: OFM
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
0.50 mg P

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
April 25, 1939 FDA LILLY

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
False negative investigation result 395.29 18.13 50 3072 89 63485811
Exposure to toxic agent 41.34 18.13 14 3108 5573 63480327
Death 30.78 18.13 61 3061 374320 63111580

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Exposure to toxic agent 30 20.86 9 1134 3666 34952122

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Exposure to toxic agent 69.01 18.47 23 3724 9135 79731506
Death 55.72 18.47 97 3650 566417 79174224

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC L03AX14 ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSTIMULANTS
IMMUNOSTIMULANTS
Other immunostimulants
ATC V04CG03 VARIOUS
DIAGNOSTIC AGENTS
OTHER DIAGNOSTIC AGENTS
Tests for gastric secretion
MeSH PA D018494 Histamine Agents
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D017442 Histamine Agonists
CHEBI has role CHEBI:25512 neurotransmitters
CHEBI has role CHEBI:75771 Mus musculus metabolites
CHEBI has role CHEBI:77746 Homo sapiens metabolite
CHEBI has role CHEBI:35678 histamine agonists

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Acute myeloid leukemia, disease indication 91861009
Hyposensitization to allergens indication 182678001
Osteoarthritis indication 396275006
Heart valve disorder contraindication 368009 DOID:4079
Ocular hypertension contraindication 4210003 DOID:9282
Alcoholism contraindication 7200002
Peptic ulcer contraindication 13200003 DOID:750
Glaucoma contraindication 23986001 DOID:1686
Feeling agitated contraindication 24199005
Hyperthyroidism contraindication 34486009 DOID:7998
Hypertensive disorder contraindication 38341003 DOID:10763
Mild pre-eclampsia contraindication 41114007
Conduction disorder of the heart contraindication 44808001
Low blood pressure contraindication 45007003
Diabetes mellitus type 1 contraindication 46635009 DOID:9744
Disorder of cardiovascular system contraindication 49601007 DOID:1287
Coronary arteriosclerosis contraindication 53741008 DOID:3393
Acute nephropathy contraindication 58574008
Substance abuse contraindication 66214007
Psychotic disorder contraindication 69322001
Abnormal vasomotor function contraindication 70670009
Pulmonary hypertension contraindication 70995007 DOID:6432
Diabetes mellitus contraindication 73211009 DOID:9351
Chronic idiopathic constipation contraindication 82934008
Secondary glaucoma contraindication 95717004
Angina pectoris contraindication 194828000
Asthma contraindication 195967001 DOID:2841
Bladder outflow obstruction contraindication 236645006
Benign prostatic hyperplasia contraindication 266569009
Edema contraindication 267038008
Retention of urine contraindication 267064002
Syncope contraindication 271594007
Arteriosclerosis obliterans contraindication 361133006 DOID:5160
Angle-closure glaucoma contraindication 392291006 DOID:13550
Respiratory insufficiency contraindication 409623005
Hypertensive urgency contraindication 443482000
Acute exacerbation of asthma contraindication 708038006
Severe Cardiac Disease contraindication




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 13.75 acidic
pKa2 9.89 Basic
pKa3 6.49 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Histamine H1 receptor GPCR AGONIST Ki 4.10 CHEMBL CHEMBL
Histamine H2 receptor GPCR Ki 4.30 CHEMBL
Histamine H4 receptor GPCR Ki 8.10 CHEMBL
Trace amine-associated receptor 1 GPCR Ki 5.51 PDSP
Histamine H3 receptor GPCR Ki 8.28 CHEMBL
Macrophage migration inhibitory factor Unclassified Ki 4.21 CHEMBL
Histamine H1 receptor GPCR EC50 6.70 CHEMBL
Histamine H2 receptor GPCR EC50 6 CHEMBL
Histamine H1 receptor GPCR EC50 5.35 CHEMBL
Histamine H3 receptor GPCR Ki 8.20 CHEMBL
Histamine H3 receptor GPCR Ki 7.17 CHEMBL
Histamine H4 receptor GPCR Ki 7.10 CHEMBL
Histamine H4 receptor GPCR Ki 7.20 CHEMBL
Histamine H3 receptor GPCR Ki 9.84 CHEMBL
Histamine H4 receptor GPCR Ki 8.22 CHEMBL

External reference:

IDSource
820484N8I3 UNII
4019776 VUID
N0000147867 NUI
D04444 KEGG_DRUG
56-92-8 SECONDARY_CAS_RN
51-74-1 SECONDARY_CAS_RN
4017469 VANDF
4019776 VANDF
4034665 VANDF
C0019588 UMLSCUI
CHEBI:18295 CHEBI
HSM PDB_CHEM_ID
CHEMBL90 ChEMBL_ID
774 PUBCHEM_CID
DB05381 DRUGBANK_ID
CHEMBL1533310 ChEMBL_ID
CHEMBL535166 ChEMBL_ID
CHEMBL3989520 ChEMBL_ID
D006632 MESH_DESCRIPTOR_UI
1204 IUPHAR_LIGAND_ID
C027556 MESH_SUPPLEMENTAL_RECORD_UI
142136 RXNORM
13994 MMSL
27199 MMSL
4827 MMSL
d03892 MMSL
003366 NDDF
003599 NDDF
004785 NDDF
1217222003 SNOMEDCT_US
54235008 SNOMEDCT_US
62666006 SNOMEDCT_US
768672006 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Histamine PositiveSkin Test Control HUMAN PRESCRIPTION DRUG LABEL 1 0268-0247 SOLUTION 2.75 mg PERCUTANEOUS BLA 19 sections
histamine positiveskin test control HUMAN PRESCRIPTION DRUG LABEL 1 0268-0248 INJECTION, SOLUTION 0.28 mg INTRADERMAL BLA 19 sections
Arthritis Pain Relief HUMAN OTC DRUG LABEL 1 0363-3035 CREAM 0.03 g TOPICAL OTC monograph not final 13 sections
Walgreens Arthritis Pain Relief Cream HUMAN OTC DRUG LABEL 1 0363-5301 CREAM 0 g TOPICAL OTC monograph not final 12 sections
Dairy Allergen Mix HUMAN OTC DRUG LABEL 38 43742-1277 LIQUID 6 [hp_X] ORAL unapproved drug other 9 sections
ActivOn Ultra Strength Arthritis HUMAN OTC DRUG LABEL 2 51068-501 STICK 0 g TOPICAL OTC MONOGRAPH NOT FINAL 15 sections
Alo Therapeutic Massage HUMAN OTC DRUG LABEL 2 51457-000 CREAM 0.10 g TOPICAL OTC monograph not final 10 sections
ALO THERAPEUTIC MASSAGE PAIN RELIEVING HUMAN OTC DRUG LABEL 2 51457-001 CREAM 0.10 g TOPICAL OTC monograph not final 12 sections
Glucosamine Cream EXTRA STRENGTH HUMAN OTC DRUG LABEL 1 52099-0008 CREAM 0.05 g TOPICAL OTC monograph not final 9 sections
Hay Fever HUMAN OTC DRUG LABEL 55 55714-2562 LIQUID 15 [hp_X] ORAL unapproved homeopathic 10 sections
BronCare HUMAN OTC DRUG LABEL 29 55714-4840 PELLET 15 [hp_X] ORAL unapproved homeopathic 10 sections
PainMD Max HUMAN OTC DRUG LABEL 2 55992-404 CREAM 3.50 mg TOPICAL OTC monograph not final 10 sections
Arthritis Pain Relief Cream HUMAN OTC DRUG LABEL 1 61577-8120 CREAM 0 g TOPICAL OTC monograph not final 9 sections
Back Pain Cream HUMAN OTC DRUG LABEL 1 61577-8121 CREAM 0.00 g TOPICAL OTC monograph not final 9 sections
Back Pain Cream HUMAN OTC DRUG LABEL 1 61577-8121 CREAM 0.00 g TOPICAL OTC monograph not final 9 sections
Hand and Wrist Pain Cream HUMAN OTC DRUG LABEL 1 61577-8122 CREAM 0 g TOPICAL OTC monograph not final 9 sections
Positive Skin Test Control - Histamine HUMAN PRESCRIPTION DRUG LABEL 1 65044-9998 INJECTION 6 mg PERCUTANEOUS BLA 20 sections
Positive Skin Test Control - Histamine HUMAN PRESCRIPTION DRUG LABEL 1 65044-9998 INJECTION 6 mg PERCUTANEOUS BLA 20 sections
Arthritis Relief HUMAN OTC DRUG LABEL 2 65121-121 CREAM 0.03 g TOPICAL OTC monograph not final 10 sections
Dr. Freds MIRACLE RUB HUMAN OTC DRUG LABEL 1 65121-403 CREAM 0.25 mg TOPICAL OTC monograph not final 12 sections
MANCORE MUSCLE MEND ROLL-ON PAIN RELIEVER HUMAN OTC DRUG LABEL 1 69198-700 LOTION 0.60 mg TOPICAL OTC monograph not final 10 sections
Simanix HUMAN PRESCRIPTION DRUG LABEL 3 69379-001 CREAM 0.04 g TOPICAL unapproved drug other 6 sections
Rematex HUMAN OTC DRUG LABEL 3 69379-012 CREAM 0.04 g TOPICAL OTC monograph not final 9 sections
Rematex HUMAN OTC DRUG LABEL 3 69379-012 CREAM 0.04 g TOPICAL OTC monograph not final 9 sections
Rematex HUMAN OTC DRUG LABEL 3 69379-012 CREAM 0.04 g TOPICAL OTC monograph not final 9 sections
Rematex HUMAN OTC DRUG LABEL 3 69379-012 CREAM 0.04 g TOPICAL OTC monograph not final 9 sections
Simanix HUMAN PRESCRIPTION DRUG LABEL 3 69379-013 CREAM 0.04 g TOPICAL unapproved drug other 6 sections
CVS Arthritis Pain Relief HUMAN OTC DRUG LABEL 1 69842-301 CREAM 0.03 g TOPICAL OTC monograph not final 13 sections
Histamine DHCl 0.10 Percent HUMAN OTC DRUG LABEL 1 70645-264 SPRAY 0.10 g TOPICAL OTC MONOGRAPH NOT FINAL 12 sections
Histamine DHCl 0.10 Percent and Menthol 2 Percent HUMAN OTC DRUG LABEL 2 70645-265 SPRAY 0.10 g TOPICAL OTC MONOGRAPH NOT FINAL 12 sections